SEC Form 4 · accession 0001127602-19-004313
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gloria M McCarthy
Officer — EVP & Chief Administrative Off
Period of report
Feb 4, 2019
Accepted (ET)
Feb 6, 2019 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 4, 2019 | M | 7,700 | $146.93 | A | 46,456 | D | |
| Common StockF2 | Feb 4, 2019 | S | 1,900 | $301.85 | D | 44,556 | D | |
| Common StockF3 | Feb 4, 2019 | S | 2,808 | $302.84 | D | 41,748 | D | |
| Common StockF4 | Feb 4, 2019 | S | 2,992 | $303.82 | D | 38,756 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F5 | $146.93 | Feb 4, 2019 | M | 7,700 | D | — | Mar 2, 2025 | Common Stock | 7,700 | 1,362 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018.
- F2This transaction was executed in multiple trades at prices ranging from $301.42 to $302.40. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $302.42 to $303.36. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $303.42 to $304.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5The option represents a right to purchase a total of 16,762 shares, and is exercisable in six semi-annual installments, with two installments of 2,793 shares each and four installments of 2,794 shares each, beginning on September 2, 2015, which is the six-month anniversary of option grant date.